News
Sometime in the future, doctors treating a patient infected with COVID-19 or lung cancer could administer a revolutionary new pharmaceutical therapy created by Madison-based biotech Nano RED. Carried ...
9d
News-Medical.Net on MSNResearchers receive $2.7 million NIH grant to develop the next generation of synthetic bloodBlood loss is the leading cause of death in trauma patients between the ages of 1 and 46 years, largely because they cannot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results